Tandem Diabetes Care Inc (TNDM)
Cash ratio
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash and cash equivalents | US$ in thousands | 69,234 | 49,039 | 47,697 | 58,979 | 58,868 | 79,611 | 130,751 | 127,762 | 172,517 | 123,786 | 114,966 | 93,681 | 71,181 | 112,375 | 98,578 | 120,791 | 94,613 | 129,481 | 222,479 | 74,485 |
Short-term investments | US$ in thousands | 369,095 | 424,266 | 404,718 | 408,831 | 409,044 | 418,547 | 376,495 | 391,826 | 444,384 | 484,941 | 520,365 | 541,710 | 552,630 | 482,618 | 446,724 | 392,646 | 390,323 | 335,041 | 203,806 | 85,723 |
Total current liabilities | US$ in thousands | 247,049 | 259,276 | 240,610 | 192,971 | 195,258 | 187,110 | 174,655 | 171,157 | 165,290 | 173,630 | 139,259 | 131,815 | 131,856 | 119,650 | 108,723 | 103,410 | 103,852 | 105,506 | 114,307 | 99,647 |
Cash ratio | 1.77 | 1.83 | 1.88 | 2.42 | 2.40 | 2.66 | 2.90 | 3.04 | 3.73 | 3.51 | 4.56 | 4.82 | 4.73 | 4.97 | 5.02 | 4.97 | 4.67 | 4.40 | 3.73 | 1.61 |
December 31, 2024 calculation
Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($69,234K
+ $369,095K)
÷ $247,049K
= 1.77
The cash ratio of Tandem Diabetes Care Inc shows the company's ability to cover its short-term obligations with cash and cash equivalents. A higher cash ratio indicates a stronger liquidity position.
Looking at the data provided:
- The cash ratio increased steadily from 1.61 as of March 31, 2020, to a peak of 5.02 as of June 30, 2021, suggesting an improvement in liquidity over this period.
- Subsequently, the cash ratio fluctuated between 4.73 and 3.04 until March 31, 2023, indicating a relatively stable liquidity position.
- However, from March 31, 2023, to December 31, 2024, the cash ratio declined continuously, reaching a low of 1.77. This downward trend indicates a potential deteriorating liquidity position over this period.
Overall, while Tandem Diabetes Care Inc initially demonstrated a strong liquidity position, the decreasing trend in the cash ratio in the latter period may raise concerns about the company's ability to cover its short-term obligations with available cash and cash equivalents. Monitoring and analyzing the factors contributing to this trend will be crucial for assessing the company's financial health and liquidity management going forward.
Peer comparison
Dec 31, 2024